Neervannan Seshadri bought TARS
March 5, 2026 · Form 4 insider transaction
Neervannan Seshadri bought 17,161 shares of Tarsus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,161
Price
$0.00
Total value
N/A
InsiderNeervannan Seshadri
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after17,161
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.; The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.